Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights| (NASDAQ: DNLI) | Delayed: 20.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.13 | 52 Week High | $ | |||
| Open | $20.13 | 52 Week Low | $ | |||
| Day High | $20.13 | P/E | N/A | |||
| Day Low | $20.13 | EPS | $ | |||
| Volume | 35 | |||||

